EP3856774

METHODS OF TREATING RESIDUAL BREAST CANCER WITH TRASTUZUMAB EMTANSINE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    24.4.2019
  • EP published:
    2.11.2022
  • EP application number:
    19732147.4
  • Max expiry date:
    23.4.2039
  • Title in English:
    METHODS OF TREATING RESIDUAL BREAST CANCER WITH TRASTUZUMAB EMTANSINE
  • Language of the patent:
    English

Timeline

Today
24.4.2019EP application
2.11.2022EP Publication

Owner

  • Name:
    F. Hoffmann-La Roche AG
  • Address:
    Grenzacherstrasse 124, 4070 Basel, CH

Inventor

  • Name:
    SMITT, Melanie
  • Address:
    South San Francisco, CA 94080, US

Priority

  • Number:
    201862745914 P
  • Date:
    15.10.2018
  • Country:
    US

Classification

  • Categories:
    C07K 16/28, A61K 31/5365, C07K 16/32, A61P 31/00, A61P 35/00, A61K 39/00

Upload documents